Ana Cavey

7.3k total citations
19 papers, 632 citations indexed

About

Ana Cavey is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Ana Cavey has authored 19 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 5 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Ana Cavey's work include Multiple Sclerosis Research Studies (14 papers), Autoimmune Neurological Disorders and Treatments (3 papers) and Ion channel regulation and function (3 papers). Ana Cavey is often cited by papers focused on Multiple Sclerosis Research Studies (14 papers), Autoimmune Neurological Disorders and Treatments (3 papers) and Ion channel regulation and function (3 papers). Ana Cavey collaborates with scholars based in United Kingdom, United States and Italy. Ana Cavey's co-authors include Jacqueline Palace, Bethan Lang, K. McKnight, Jackie Palace, S. Wroe, Miri Blank, A. Vincent, Yanyan Jiang, Y Hart and Yehuda Shoenfeld and has published in prestigious journals such as NeuroImage, Brain and Neurology.

In The Last Decade

Ana Cavey

19 papers receiving 621 citations

Peers

Ana Cavey

NEURO

PFM

CMN

PMH

Johann Penzien Germany

Krystyna Mitosek‐Szewczyk Poland

Е. И. Гусев Russia

Kristin N. Varhaug Norway

Tiina Keränen Finland

M. Gironi Italy

Gabriela Kłodowska-Duda Poland

D. Scalabrini Italy

Antonio Garcı́a-Merino Spain

Yannick Tholance France

Johann Penzien Germany

Ana Cavey

143 ×0.5

NEURO

96 ×0.4

PFM

268 ×1.4

106 ×1.1

CMN

42 ×0.5

PMH

Citations per year, relative to Ana Cavey Ana Cavey (= 1×) peers Johann Penzien

Countries citing papers authored by Ana Cavey

Since Specialization

Citations

This map shows the geographic impact of Ana Cavey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Cavey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Cavey more than expected).

Fields of papers citing papers by Ana Cavey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Cavey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Cavey. The network helps show where Ana Cavey may publish in the future.

Co-authorship network of co-authors of Ana Cavey

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Cavey. A scholar is included among the top collaborators of Ana Cavey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Cavey. Ana Cavey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Messina, Silvia, Romina Mariano, Adriana Roca‐Fernández, et al.. (2021). Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis. Multiple Sclerosis Journal. 28(2). 217–227. 40 indexed citations

Dobson, Ruth, Matthew Craner, Aleisha Miller, et al.. (2021). OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis. BMJ Open. 11(11). e050176–e050176. 2 indexed citations

Messina, Silvia, Romina Mariano, Ruth Geraldes, et al.. (2021). The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 49. 102773–102773. 7 indexed citations

Tackley, George, Yazhuo Kong, Silvia Messina, et al.. (2021). An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue. NeuroImage. 238. 118225–118225. 9 indexed citations

Mansoubi, Maedeh, Susan G. Coe, Miriam Clegg, et al.. (2021). Physical Activity and Fatigue in Multiple Sclerosis: Secondary Outcomes from a Double-blinded Randomized Controlled Trial of Cocoa Flavonoid Drinks. 53–61. 1 indexed citations

Coe, Susan G., Johnny Collett, Andrew Soundy, et al.. (2019). A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 90(5). 507–513. 24 indexed citations

Yeo, Tianrong, Fay Probert, Maciej Juryńczyk, et al.. (2019). Classifying the antibody-negative NMO syndromes. Neurology Neuroimmunology & Neuroinflammation. 6(6). e626–e626. 25 indexed citations

Coe, Susan G., Johnny Collett, H. Izadi, et al.. (2018). A protocol for a randomised double-blind placebo-controlled feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue in people with relapsing and remitting multiple sclerosis (RRMS). Pilot and Feasibility Studies. 4(1). 35–35. 4 indexed citations

Juryńczyk, Maciej, Fay Probert, Tianrong Yeo, et al.. (2017). Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease. Acta Neuropathologica Communications. 5(1). 95–95. 43 indexed citations

10.

Huda, Saif, et al.. (2016). Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability. Journal of the Neurological Sciences. 362. 66–68. 10 indexed citations

11.

Cruz, Pedro M. Rodríguez, Lucy Matthews, Mike Boggild, et al.. (2016). Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom. JAMA Neurology. 73(8). 954–954. 15 indexed citations

12.

Piccolo, Laura, Ichiro Nakashima, Tatsuro Misu, et al.. (2015). Multiple sclerosis in Japan appears to be a milder disease compared to the UK. Journal of Neurology. 262(4). 831–836. 45 indexed citations

13.

Dickens, Alex M., James R. Larkin, Julian L. Griffin, et al.. (2014). A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis. Neurology. 83(17). 1492–1499. 64 indexed citations

14.

Arun, Tarunya, Valentina Tomassini, Emilia Sbardella, et al.. (2013). Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride. Brain. 136(1). 106–115. 111 indexed citations

15.

Collett, Johnny, Helen Dawes, Ana Cavey, et al.. (2011). Hydration and independence in activities of daily living in people with multiple sclerosis: a pilot investigation. Disability and Rehabilitation. 33(19-20). 1822–1825. 4 indexed citations

16.

Stagg, Charlotte J., Bethan Lang, Jonathan G. Best, et al.. (2010). Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels. Epilepsia. 51(9). 1898–1901. 41 indexed citations

17.

Cavey, Ana, et al.. (2005). The evaluation of a novel "goat serum" therapy (Aimspro) in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 76. 1326–1326. 1 indexed citations

18.

McKnight, K., Yanyan Jiang, Y Hart, et al.. (2005). Serum antibodies in epilepsy and seizure-associated disorders. Neurology. 65(11). 1730–1736. 184 indexed citations

19.

Lang, Bethan, et al.. (2004). The clinical phenotype of non-paraneoplastic voltage gated potassium channel antibody (VGKC Ab) associated CNS disease. Journal of Neurology Neurosurgery & Psychiatry. 75(3). 518–518. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact